These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 9060675)

  • 1. Suppression of human immunodeficiency virus type 1 replication by CD8+ cells: evidence for HLA class I-restricted triggering of cytolytic and noncytolytic mechanisms.
    Yang OO; Kalams SA; Trocha A; Cao H; Luster A; Johnson RP; Walker BD
    J Virol; 1997 Apr; 71(4):3120-8. PubMed ID: 9060675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficient lysis of human immunodeficiency virus type 1-infected cells by cytotoxic T lymphocytes.
    Yang OO; Kalams SA; Rosenzweig M; Trocha A; Jones N; Koziel M; Walker BD; Johnson RP
    J Virol; 1996 Sep; 70(9):5799-806. PubMed ID: 8709196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual function of a human immunodeficiency virus (HIV)-specific cytotoxic T-lymphocyte clone: inhibition of HIV replication by noncytolytic mechanisms and lysis of HIV-infected CD4+ cells.
    Buseyne F; Février M; Garcia S; Gougeon ML; Rivière Y
    Virology; 1996 Nov; 225(1):248-53. PubMed ID: 8918556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinetics of antiviral activity by human immunodeficiency virus type 1-specific cytotoxic T lymphocytes (CTL) and rapid selection of CTL escape virus in vitro.
    Van Baalen CA; Schutten M; Huisman RC; Boers PH; Gruters RA; Osterhaus AD
    J Virol; 1998 Aug; 72(8):6851-7. PubMed ID: 9658134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Noncytolytic inhibition of X4 virus by bulk CD8(+) cells from human immunodeficiency virus type 1 (HIV-1)-infected persons and HIV-1-specific cytotoxic T lymphocytes is not mediated by beta-chemokines.
    Geiben-Lynn R; Kursar M; Brown NV; Kerr EL; Luster AD; Walker BD
    J Virol; 2001 Sep; 75(17):8306-16. PubMed ID: 11483776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different effects of Nef-mediated HLA class I down-regulation on human immunodeficiency virus type 1-specific CD8(+) T-cell cytolytic activity and cytokine production.
    Tomiyama H; Akari H; Adachi A; Takiguchi M
    J Virol; 2002 Aug; 76(15):7535-43. PubMed ID: 12097566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of simian immunodeficiency virus (SIV) replication by CD8(+) T lymphocytes from macaques immunized with live attenuated SIV.
    Gauduin MC; Glickman RL; Means R; Johnson RP
    J Virol; 1998 Aug; 72(8):6315-24. PubMed ID: 9658070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD8(+)-Cell antiviral factor activity is not restricted to human immunodeficiency virus (HIV)-specific T cells and can block HIV replication after initiation of reverse transcription.
    Le Borgne S; Février M; Callebaut C; Lee SP; Rivière Y
    J Virol; 2000 May; 74(10):4456-64. PubMed ID: 10775581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative clonal analysis of human immunodeficiency virus type 1 (HIV-1)-specific CD4+ and CD8+ cytolytic T lymphocytes isolated from seronegative humans immunized with candidate HIV-1 vaccines.
    Hammond SA; Bollinger RC; Stanhope PE; Quinn TC; Schwartz D; Clements ML; Siliciano RF
    J Exp Med; 1992 Dec; 176(6):1531-42. PubMed ID: 1460417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lysis of CD4+ lymphocytes by non-HLA-restricted cytotoxic T lymphocytes from HIV-infected individuals.
    Grant MD; Smaill FM; Rosenthal KL
    Clin Exp Immunol; 1993 Sep; 93(3):356-62. PubMed ID: 8103717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human immunodeficiency virus type 1-specific cytotoxic T lymphocytes release gamma interferon, tumor necrosis factor alpha (TNF-alpha), and TNF-beta when they encounter their target antigens.
    Jassoy C; Harrer T; Rosenthal T; Navia BA; Worth J; Johnson RP; Walker BD
    J Virol; 1993 May; 67(5):2844-52. PubMed ID: 7682629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD8+ T Cell Breadth and Ex Vivo Virus Inhibition Capacity Distinguish between Viremic Controllers with and without Protective HLA Class I Alleles.
    Koofhethile CK; Ndhlovu ZM; Thobakgale-Tshabalala C; Prado JG; Ismail N; Mncube Z; Mkhize L; van der Stok M; Yende N; Walker BD; Goulder PJR; Ndung'u T
    J Virol; 2016 Aug; 90(15):6818-6831. PubMed ID: 27194762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta-chemokines are released from HIV-1-specific cytolytic T-cell granules complexed to proteoglycans.
    Wagner L; Yang OO; Garcia-Zepeda EA; Ge Y; Kalams SA; Walker BD; Pasternack MS; Luster AD
    Nature; 1998 Feb; 391(6670):908-11. PubMed ID: 9495345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of a major histocompatibility complex class I-restricted cytotoxic T-lymphocyte response to a highly conserved region of human immunodeficiency virus type 1 (HIV-1) gp120 in seronegative humans immunized with a candidate HIV-1 vaccine.
    Johnson RP; Hammond SA; Trocha A; Siliciano RF; Walker BD
    J Virol; 1994 May; 68(5):3145-53. PubMed ID: 7908700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of dominant optimal HLA-B60- and HLA-B61-restricted cytotoxic T-lymphocyte (CTL) epitopes: rapid characterization of CTL responses by enzyme-linked immunospot assay.
    Altfeld MA; Trocha A; Eldridge RL; Rosenberg ES; Phillips MN; Addo MM; Sekaly RP; Kalams SA; Burchett SA; McIntosh K; Walker BD; Goulder PJ
    J Virol; 2000 Sep; 74(18):8541-9. PubMed ID: 10954555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recognition patterns of HLA-A2-restricted human immunodeficiency virus-1-specific cytotoxic T-lymphocytes in a cohort of HIV-1-infected individuals.
    Schmitt-Haendle M; Bachmann O; Harrer E; Schmidt B; Bäuerle M; Harrer T
    Viral Immunol; 2005; 18(4):627-36. PubMed ID: 16359229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T cell receptor usage and fine specificity of human immunodeficiency virus 1-specific cytotoxic T lymphocyte clones: analysis of quasispecies recognition reveals a dominant response directed against a minor in vivo variant.
    Kalams SA; Johnson RP; Dynan MJ; Hartman KE; Harrer T; Harrer E; Trocha AK; Blattner WA; Buchbinder SP; Walker BD
    J Exp Med; 1996 Apr; 183(4):1669-79. PubMed ID: 8666925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA-E-restricted CD8
    La Manna MP; Orlando V; Prezzemolo T; Di Carlo P; Cascio A; Delogu G; Poli G; Sullivan LC; Brooks AG; Dieli F; Caccamo N
    Am J Respir Cell Mol Biol; 2020 Apr; 62(4):430-439. PubMed ID: 31697586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-cytolytic control of HIV replication by CD8+ T cells.
    Walker CM
    Semin Immunol; 1993 Jun; 5(3):195-201. PubMed ID: 8102264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV-1 proteins in infected cells determine the presentation of viral peptides by HLA class I and class II molecules and the nature of the cellular and humoral antiviral immune responses--a review.
    Becker Y
    Virus Genes; 1994 Jul; 8(3):249-70. PubMed ID: 7975271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.